• RCM Technologies, Inc. Announces Second-Quarter Results

    Источник: Nasdaq GlobeNewswire / 07 авг 2024 15:05:00   America/Chicago

    PENNSAUKEN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and twenty-six weeks ended June 29, 2024.

    RCM Technologies reported revenue of $69.2 million for the thirteen weeks ended June 29, 2024 (the current quarter), an increase of 3.2% compared to $67.0 million for the thirteen weeks ended July 1, 2023 (the comparable prior quarter). Gross profit was $20.0 million for the current quarter, a 6.6% increase compared to $18.8 million for the comparable prior quarter.  The Company experienced GAAP net income of $3.8 million, or $0.47 per diluted share, for the current quarter compared to $4.0 million, or $0.47 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $7.2 million for the current quarter, a 10.8% increase compared to $6.5 million for the comparable prior quarter. The Company experienced $0.56 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.50 for the comparable prior quarter.

    RCM Technologies reported revenue of $141.1 million for the twenty-six weeks ended June 29, 2024 (the current period), an increase of 5.2% compared to $134.2 million for the twenty-six weeks ended July 1, 2023 (the comparable prior-year period). Gross profit was $40.4 million for the current period, a 6.8% increase compared to $37.8 million for the comparable prior-year period.  The Company experienced GAAP net income of $7.7 million, or $0.95 per diluted share, for the current period compared to $7.8 million, or $0.87 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA (non-GAAP) of $14.0 million for the current period, a 10.9% increase compared to $12.6 million for the comparable prior-year period. The Company experienced $1.10 of adjusted net income per diluted share (non-GAAP) for the current period as compared to $0.92 for the comparable prior-year period.

    Bradley Vizi, Executive Chairman of RCM Technologies, commented, “Second quarter growth was led by Engineering, as project activity continues to ramp building on the foundation carefully laid over the last several years.”

    Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “Our strong cash generating business model allows us to fund growth, while remaining opportunistic and actively managing our capital structure.”

    Conference Call
    On Thursday, August 8, 2024, RCM Technologies will host a conference call to discuss these results. The call will begin at 1:00 p.m. Eastern Time. The dial-in number is (888) 272-8703.

    About RCM
    RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

    The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.


    RCM Technologies, Inc.
    Condensed Consolidated Statements of Operations
    (Unaudited)
    (In Thousands, Except Per Share Amounts)

     Thirteen Weeks Ended 
     June 29,
    2024
     July 1,
    2023
     
    Revenue$69,164 $67,035 
    Cost of services 49,163  48,275 
    Gross profit 20,001  18,760 
    Selling, general and administrative 13,545  12,723 
    Depreciation and amortization of property and equipment 332  242 
    Amortization of acquired intangible assets 46  46 
    Costs associated with potential stock issuance 259  - 
    Operating income 5,819  5,749 
    Other expense, net 574  418 
    Income before income taxes 5,245  5,331 
    Income tax expense 1,483  1,348 
    Net income$3,762 $3,983 
         
    Diluted net earnings per share data$0.47 $0.47 
    Diluted weighted average shares outstanding 7,955,943  8,558,396 


     Twenty-Six Weeks Ended 
     June 29,
    2024
     July 1,
    2023
     
    Revenue$141,103 $134,159 
    Cost of services 100,735  96,375 
    Gross profit 40,368  37,784 
    Selling, general and administrative 27,744  26,119 
    Depreciation and amortization of property and equipment 619  513 
    Amortization of acquired intangible assets 91  91 
    Costs associated with potential stock issuance 259  - 
    Gain on sale of assets -  (395)
    Operating income 11,655  11,456 
    Other expense, net 1,000  825 
    Income before income taxes 10,655  10,631 
    Income tax expense 2,941  2,811 
    Net income$7,714 $7,820 
         
    Diluted net earnings per share data$0.95 $0.87 
    Diluted weighted average shares outstanding 8,078,049  8,976,714 



    RCM Technologies, Inc.
    Supplemental Operating Results on a Non-GAAP Basis
    (Unaudited)
    (In Thousands)

    The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA,” “Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance.  In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

    The following unaudited table presents the Company’s GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen and twenty-six weeks ended June 29, 2024 and July 1, 2023. 


     Thirteen Weeks Ended Twenty-Six Weeks Ended 
     June 29,
    2024
     July 1,
    2023
     June 29,
    2024
     July 1,
    2023
     
     (Unaudited) (Unaudited) (Unaudited) (Unaudited) 
             
    GAAP operating income$5,819 $5,749 $11,655 $11,456 
    Adjustments        
    Gain on sale of assets -  -  -  (395)
    Costs associated with potential stock issuance 259  -  259  - 
    Equity compensation 752  471  1,387  967 
    Adjusted operating income (non-GAAP)$6,830 $6,220 $13,301 $12,028 
             
    GAAP net income$3,762 $3,983 $7,714 $7,820 
    Income tax expense 1,483  1,348  2,941  2,811 
    Interest expense, net 581  425  1,059  785 
    Depreciation of property and equipment 332  242  619  513 
    Amortization of acquired intangible assets 46  46  91  91 
    EBITDA (non-GAAP)$6,204 $6,044 $12,424 $12,020 
             
    Adjustments        
    Gain on sale of assets -  -  -  (395)
    Costs associated with potential stock issuance 259  -  259  - 
    (Gain) loss on foreign currency transactions (7) (7) (59) 40 
    Equity compensation 752  471  1,387  967 
    Adjusted EBITDA (non-GAAP)$7,208 $6,508 $14,011 $12,632 



    RCM Technologies, Inc.
    Supplemental Operating Results on a Non-GAAP Basis (Continued)
    (Unaudited)
    (In Thousands)

     Thirteen Weeks Ended Twenty-Six Weeks Ended 
     June 29,
    2024
     July 1,
    2023
     June 29,
    2024
     July 1,
    2023
     
     (Unaudited) (Unaudited) (Unaudited) (Unaudited) 
             
    GAAP net income$3,762 $3,983 $7,714 $7,820 
    Adjustments        
    Gain on sale of assets -  -  -  (395)
    Costs associated with potential stock issuance 259  -  259  - 
    (Gain) loss on foreign currency transactions (7) (7) (59) 40 
    Equity compensation 752  471  1,387  967 
    Tax impact from normalized rate (276) (128) (444) (168)
    Adjusted net income (non-GAAP)$4,490 $4,319 $8,857 $8,264 
             
    GAAP diluted net earnings per share$0.47 $0.47 $0.95 $0.87 
    Adjustments        
    Gain on sale of assets -  -  - ($0.04)
    Costs associated with potential stock issuance$0.03  - $0.03  - 
    (Gain) loss on foreign currency transactions -  -  - $0.01 
    Equity compensation$0.09 $0.05 $0.17 $0.10 
    Tax impact from normalized rate($0.03)($0.02)($0.05)($0.02)
    Adjusted diluted net earnings per share (non-GAAP)$0.56 $0.50 $1.10 $0.92 



    RCM Technologies, Inc.
    Summary of Selected Income Statement Data
    (Unaudited)
    (In Thousands)

     Thirteen Weeks Ended June 29, 2024 
     Specialty
    Health Care
     Engineering Life Sciences
    and IT
     

    Consolidated
     
             
    Revenue$36,932 $22,508 $9,724 $69,164 
    Cost of services 26,293  16,542  6,328  49,163 
    Gross profit$10,639 $5,966 $3,396 $20,001 
    Gross profit margin 28.8% 26.5% 34.9% 28.9%


     Thirteen Weeks Ended July 1, 2023 
     Specialty
    Health Care
     Engineering Life Sciences
    and IT
     

    Consolidated
     
             
    Revenue$35,528 $21,014 $10,493 $67,035 
    Cost of services 25,727  16,192  6,356  48,275 
    Gross profit$9,801 $4,822 $4,137 $18,760 
    Gross profit margin 27.6% 22.9% 39.4% 28.0%


     Twenty-Six Weeks Ended June 29, 2024 
     Specialty
    Health Care
     Engineering Life Sciences
    and IT
     

    Consolidated
     
             
    Revenue$75,114 $46,013 $19,976 $141,103 
    Cost of services 53,409  34,540  12,786  100,735 
    Gross profit$21,705 $11,473 $7,190 $40,368 
    Gross profit margin 28.9% 24.9% 36.0% 28.6%


     Twenty-Six Weeks Ended July 1, 2023 
     Specialty
    Health Care
     Engineering Life Sciences
    and IT
     

    Consolidated
     
             
    Revenue$74,658 $39,504 $19,997 $134,159 
    Cost of services 53,185  30,365  12,555  96,375 
    Gross profit$21,473 $8,869 $7,442 $37,784 
    Gross profit margin 28.8% 22.5% 37.2% 28.2%



    RCM Technologies, Inc.
    Condensed Consolidated Balance Sheets
    (Unaudited)
    (In Thousands, Except Share Amounts)

     June 29, December 30, 
     2024 2023 
     (Unaudited)   
    Current assets:    
     Cash and cash equivalents$3,480 $6,284 
     Accounts receivable, net of provision for credit losses of $1,600
    on June 29, 2024 and December 30, 2023
     66,915  

    70,690
     
     Transit accounts receivable 9,460  8,891 
     Prepaid expenses and other current assets 5,432  4,637 
      Total current assets 85,287  90,502 
           
    Property and equipment, net 4,451  4,005 
         
    Deposits 203  313 
    Deferred income taxes, foreign 53  55 
    Goodwill 22,147  22,147 
    Operating right of use asset 5,545  2,779 
    Intangible assets, net 592  683 
      Total other assets 28,540  25,977 
           
      Total assets$118,278 $120,484 


    Current liabilities:    
     Accounts payable and accrued expenses$12,917 $12,454 
     Transit accounts payable 30,925  31,102 
     Accrued payroll and related costs 9,710  11,203 
     Finance lease payable -  233 
     Income taxes payable 136  330 
     Operating right of use liability 983  693 
     Contingent consideration from acquisitions 300  300 
     Deferred revenue 2,678  1,881 
      Total current liabilities 57,649  58,196 
         
    Deferred income taxes, net, foreign 183  187 
    Deferred income taxes, net, domestic 1,669  1,568 
    Contingent consideration from acquisitions, net of current position 1,671  1,671 
    Operating right of use liability, net of current position 4,784  2,268 
    Borrowings under line of credit 23,870  30,804 
     Total liabilities 89,826  94,694 
         
    Contingencies (note 15) -  - 
         
    Stockholders’ equity:    
     Preferred stock, $1.00 par value; 5,000,000 shares authorized;    
      no shares issued or outstanding -  - 
     Common stock, $0.05 par value; 40,000,000 shares authorized;    
      17,775,693 shares issued and 7,666,709 shares outstanding at
    June 29, 2024 and 17,673,427 shares issued and 7,844,821 shares
    outstanding at December 30, 2023
     887  882 
     Additional paid-in capital 117,008  116,579 
     Accumulated other comprehensive loss (2,908) (2,813)
     Accumulated deficit (11,551) (19,265)
     Treasury stock, 10,108,984 shares at June 29, 2024 and    
      9,828,606 shares at December 30, 2023, at cost (74,984) (69,593)
      Total stockholders’ equity 28,452  25,790 
           
      Total liabilities and stockholders’ equity$118,278 $120,484 



    RCM Technologies, Inc.
    Condensed Consolidated Statements of Cash Flows
    (Unaudited)
    (In Thousands)

     Thirteen Weeks Ended  
     June 29,
    2024
     July 1,
    2023
     
    Net income$3,762 $3,983 
    Adjustments to reconcile net income to cash
    used in operating activities
     1,442  1,043 
    Changes in operating assets and liabilities:    
     Accounts receivable 6,628  (2,804)
     Prepaid expenses and other current assets (916) (648)
     Net of transit accounts receivable and payable (527) 19,356 
     Accounts payable and accrued expenses (660) 654 
     Accrued payroll and related costs (2,462) (3,598)
     Right of use liabilities (154) (335)
     Income taxes payable (638) 6 
     Deferred revenue (836) (305)
     Deposits 86  (9)
    Total adjustments 1,963  13,360 
    Net cash provided by (used in) operating activities$5,725 $17,343 
         
    Net cash used in investing activities (398) (227)
    Net cash used in financing activities (3,796) (17,631)
    Effect of exchange rate changes on cash and cash equivalents (150) (37)
    Increase (decrease) in cash and cash equivalents$1,381 ($552)


     Twenty-Six Weeks Ended 
     June 29,
    2024
     July 1,
    2023
     
    Net income$7,714 $7,820 
    Adjustments to reconcile net income to cash
    used in operating activities
     2,692  1,746 
    Changes in operating assets and liabilities:    
     Accounts receivable 3,826  (10,839)
     Prepaid expenses and other current assets (796) 312 
     Net of transit accounts receivable and payable (746) 20,828 
     Accounts payable and accrued expenses 685  (1,013)
     Accrued payroll and related costs (1,486) (1,194)
     Right of use liabilities (458) (683)
     Income taxes payable (187) 147 
     Deferred revenue 797  (615)
     Deposits 110  2 
    Total adjustments 4,437  8,691 
    Net cash provided by operating activities$12,151 $16,511 
         
    Net cash used in investing activities (1,067) (559)
    Net cash used in financing activities (13,510) (15,215)
    Effect of exchange rate changes on cash and cash equivalents (378) 197 
    (Decrease) increase in cash and cash equivalents($2,804)$934 



    RCM Technologies, Inc.   Tel: 856.356.4500         Corporate Contacts:
    2500 McClellan Avenue   info@rcmt.com      Bradley S. Vizi
    Pennsauken, NJ 08109    www.rcmt.com     Executive Chairman
              Kevin D. Miller  
              Chief Financial Officer

    Primary Logo

Опубликовать